Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

scientific article published on 01 July 1998

Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S005200050184
P698PubMed publication ID9695210

P2093author name stringH J Senn
U Hess
C Böhme
K Rey
P433issue4
P921main subjectamikacinQ408529
ceftazidimeQ808845
piperacillin/tazobactamQ7197337
P304page(s)402-409
P577publication date1998-07-01
P1433published inSupportive Care in CancerQ15766919
P1476titleMonotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients
P478volume6

Reverse relations

cites work (P2860)
Q45305512A Comparative Study of Piperacillin-Tazobactam With and Without Vancomycin as Empirical Therapy for Febrile Neutropenic Patients With Solid Tumor Malignancies
Q90284827A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient
Q34180913Aminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation
Q24201767Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
Q24248048Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
Q33809969Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer
Q44655203Comparative in vitro activity of piperacillin, piperacillin–sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients
Q40601273Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)
Q34305094Infections following hematopoietic stem cell transplantation
Q40585149Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis
Q43890461Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections
Q40177437Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey
Q40561453Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Q40489194Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial
Q34458678Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections
Q33649676Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections
Q73829631[Impact of oral prophylaxis with quinolones on microbial agents isolated from blood cultures during febrile episodes in hematologic patients]